If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

Share Price Information for BBGI Global Infrastructure (BBGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.60
Bid: 141.40
Ask: 141.60
Change: 1.20 (0.85%)
Spread: 0.20 (0.141%)
Open: 140.60
High: 142.40
Low: 140.40
Prev. Close: 140.40
BBGI Live PriceLast checked at -
BBGI SICAV S.A. is an Investment Trust

To provide a unique access to a global portfolio of high-quality infrastructure assets which generate stable, predictable cash flows over the life of government or government-backed contracts that typically extend to more than twenty years in length.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

5 Mar 2020 07:00

RNS Number : 9719E
BBGI SICAV S.A.
05 March 2020
 

5 March 2020

 

 

 

 

BBGI SICAV S.A.

(the "Company")

 

Acquisition of interest in one new availability-based project and a further interest in Stanton Hospital

 

 

BBGI SICAV S.A. (LSE ticker: BBGI), the global infrastructure investment

Company is pleased to announce two recent investment acquisitions.

 

Stanton Hospital

BBGI has completed the acquisition of a further 25% equity interest in the Stanton Territorial Hospital Project ("Stanton"). Stanton is an operational 27,000 m2 hospital with 100 patient rooms located in Yellowknife, Northwest Territories, Canada. The asset is classified as availability-based under the investment policy of the Company. The concession runs until 2048 and availability payments are received from the Government of Northwest Territories, which is rated Aa1 by the credit rating agency Moody's. BBGI's interest in the project is now 50%.

 

The contractual arrangements between the parties require that the exact purchase price be held confidential but can be confirmed to be less than GBP 10 million.

 

Duncan Ball, Co-CEO said: "We are delighted to make a follow-on investment into this important healthcare facility. This acquisition was made on accretive terms and concluded without engaging in an auction process."

 

Highway 104

BBGI, together with its consortium partners, was recently named as the preferred bidder for an availability-based motorway project in Canada that will twin Highway 104 between Sutherlands River and Antigonish in Nova Scotia. Financial close is expected in Q2 2020. Construction is scheduled to begin this spring, with completion expected in 2023. The concession will run until 2043 and availability payments will be received from the Government of Nova Scotia, which is rated Aa2 by Moody's and AA- by Standard & Poor's. BBGI's equity interest in the project will be 50%.

 

 

The cash consideration for both interests in Stanton Hospital and Highway 104 will be funded from the Company's existing cash resources and/or debt facilities.

 

Frank Schramm, Co-CEO said: "We are excited to be involved in the development of this important infrastructure project. The project will improve travel efficiency and safety within Nova Scotia and will create jobs for local workers."

 

For further information, please contact:

BBGI Management Team +352202634791

Duncan Ball

Frank Schramm

 

 

BBGI owns a diversified global portfolio of 48 infrastructure assets spread across seven AAA/AA rated countries. All these projects are availability based assets and are supported by contracted, public sector-backed revenue streams, with inflation-protection characteristics.

 

Further information about BBGI is available on its website at www.bb-gi.com*.

 

The Company's LEI is LEI: 529900CV0RWCOP5YHK95

 

Any reference to the Company or BBGI refers also to its subsidiaries (where applicable).

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on its website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQVZLBBBXLBBBV
Date   Source Headline
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSResult of AGM
25th Apr 202411:33 amRNSAnnual Financial Report for year ended 31-Dec-2023
9th Apr 20244:02 pmRNSDirector/PDMR Shareholding
4th Apr 20241:26 pmRNSDirector/PDMR Shareholding
4th Apr 202410:11 amRNSResults analysis from Kepler Trust Intelligence
2nd Apr 20243:59 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSPeriodic SFDR Disclosure
28th Mar 20247:00 amRNSAnnual Results - financial year ended 31-Dec-2023
27th Mar 20245:02 pmRNSNotice of AGM
14th Mar 20247:00 amRNSRetail Investor Results - Investor Meet Company
26th Feb 20247:00 amRNSDate of Annual Results
15th Feb 20247:00 amRNSSecond Interim Dividend
9th Feb 20247:00 amRNSGrant of Share Awards under LTIP
31st Jan 20243:59 pmRNSDirectorate Change
12th Dec 20232:48 pmRNSDirector/PDMR Shareholding
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20239:52 amRNSDirector/PDMR Shareholding
4th Dec 202310:23 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSKepler Trust Intelligence: New Research
28th Nov 20234:09 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSDirectorate Change
27th Oct 20239:59 amRNSHolding(s) in Company
29th Sep 202310:02 amRNSTotal Voting Rights
29th Sep 20239:58 amRNSHolding(s) in Company
12th Sep 20233:26 pmRNSHalf-year Report
4th Sep 20237:00 amRNSSubstantial Completion Achieved On Highway 104
31st Aug 20237:00 amRNSDividend Declaration
31st Aug 20237:00 amRNSAdditional Listing
31st Aug 20237:00 amRNSHalf-year Report
16th Aug 20237:00 amRNSNotice of Interim Results and Results Presentation
13th Jul 20231:32 pmRNSHolding(s) in Company
30th Jun 20233:50 pmRNSDisclosure re SFDR
20th Jun 20234:50 pmRNSDirector/PDMR Shareholding
12th Jun 20237:50 amRNSPublication of 2022 ESG Report
1st Jun 20238:29 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSKepler Trust Intelligence: New Research
31st May 20232:36 pmRNSTotal Voting Rights
26th May 202310:07 amRNSAdditional Listing
10th May 202310:55 amRNSAnnual Financial Report for year ended 31 Dec 2022
28th Apr 20233:13 pmRNSTotal Voting Rights
28th Apr 20231:46 pmRNSResult of AGM
26th Apr 20232:25 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSAdditional Listing
30th Mar 20237:00 amRNSAnnual Results financial year ended 31-Dec-2022
28th Mar 20231:58 pmRNSNotice of AGM
3rd Mar 20234:34 pmRNSScrip Dividend Circular
16th Feb 20237:00 amRNSDividend Declaration
7th Feb 20237:00 amRNSDate of Annual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.